Issue: July/August 2013
July 01, 2013
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
STAAR gains marketing approval for Visian ICLs in Argentina, Korea
Issue: July/August 2013
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Korea and Argentina have granted regulatory approvals to STAAR Surgical to market its Visian Implantable Collamer Lens with CentraFLOW, according to a company news release.
STAAR’s proprietary CentraFLOW technology is designed to improve the flow of fluid within the eye, the release said. It is also meant to allow for an easier procedure by removing the need for a YAG peripheral iridotomy several days before the Visian ICL is implanted.
The approvals on the device extend from 0.5 D to 18 D on the myopic range and from +0.5 cylinder power to +6 for the toric ICL models, according to the release.
A launch symposium is planned for July 27 in Korea to train approximately 100 surgeons on how to use the new technology.